Geode Capital Management LLC Raises Holdings in Kewaunee Scientific Co. (NASDAQ:KEQU)

Geode Capital Management LLC lifted its holdings in Kewaunee Scientific Co. (NASDAQ:KEQU) by 8.9% in the 3rd quarter, Holdings Channel reports. The firm owned 23,784 shares of the technology company’s stock after acquiring an additional 1,941 shares during the period. Geode Capital Management LLC’s holdings in Kewaunee Scientific were worth $792,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of KEQU. De Lisle Partners LLP raised its position in Kewaunee Scientific by 36.6% in the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after buying an additional 11,511 shares during the last quarter. Renaissance Technologies LLC grew its stake in shares of Kewaunee Scientific by 13.4% in the second quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock worth $4,230,000 after acquiring an additional 10,580 shares during the period. State Street Corp bought a new stake in shares of Kewaunee Scientific in the third quarter worth approximately $266,000. Dimensional Fund Advisors LP raised its holdings in shares of Kewaunee Scientific by 3.6% during the second quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock valued at $8,378,000 after purchasing an additional 6,132 shares during the last quarter. Finally, Heron Bay Capital Management bought a new position in Kewaunee Scientific during the second quarter valued at approximately $252,000. 32.69% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Wednesday, December 18th.

Insider Buying and Selling at Kewaunee Scientific

In other news, VP Elizabeth D. Phillips sold 1,850 shares of the firm’s stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $54.17, for a total value of $100,214.50. Following the transaction, the vice president now owns 13,591 shares of the company’s stock, valued at $736,224.47. This trade represents a 11.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Thomas David Hull III sold 2,000 shares of the stock in a transaction that occurred on Thursday, December 26th. The stock was sold at an average price of $63.01, for a total transaction of $126,020.00. Following the completion of the sale, the chief executive officer now directly owns 42,497 shares of the company’s stock, valued at $2,677,735.97. This represents a 4.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 9,369 shares of company stock worth $572,751 in the last three months. 14.20% of the stock is currently owned by company insiders.

Kewaunee Scientific Stock Down 5.8 %

Kewaunee Scientific stock opened at $57.73 on Friday. Kewaunee Scientific Co. has a one year low of $27.00 and a one year high of $67.20. The stock has a fifty day moving average of $48.37 and a 200 day moving average of $44.91. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.00 and a current ratio of 2.53. The stock has a market cap of $165.80 million, a PE ratio of 9.15 and a beta of 0.72.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.